Contemporary Clinical Management Of Acute Pulmonary Embolism — COPE  

Acute Pulmonary Embolism Clinical Trial

Official title: Contemporary Clinical Management Of Acute Pulmonary Embolism. The COPE Study

Status Completed

Clinical Trial Summary

Acute pulmonary embolism is a potentially life-threatening disease with short-term mortality ranges from less than 1% to more than 30% during the hospital stay. Recent guidelines recommend to tailor diagnosis hospitalization and acute treatment based on the estimated risk for short-term Death.

The assessment of the contemporary clinical management of patients with acute pulmonary embolism across different specialties would be of crucial value.

Clinical Trial Description

This is a prospective, non-interventional, multicenter study in patients with acute pulmonary embolism admitted to Cardiology, Emergency and Internal Medicine Departments in Italy.

The aim of the study is to assess contemporary management strategies in patients with acute pulmonary embolism in terms of diagnosis, risk stratification, hospitalization and treatment in Italy and assess

1. their association with in-hospital and 30-day mortality and

2. their adherence to current guidelines of the European Society of Cardiology (ESC). ;

Related Conditions & MeSH terms

• Acute Pulmonary Embolism
• Embolism
• Pulmonary Embolism

• NCT number: NCT03631810
• Study type: Observational [Patient Registry]
• Source: Heart Care Foundation
• Status: Completed
• Start date: March 15, 2018
• Completion date: February 17, 2021